1. Current Status, Position

Teun van Gelder is Professor in Clinical Pharmacology at Leiden University Medical Center, in Leiden (The Netherlands). He is involved in the research theme Academic Pharma.

2. Education

Teun van Gelder was trained in internal medicine and nephrology at the Erasmus Medical Center, and in clinical pharmacology in Nijmegen. He completed his thesis in 1996 on the use of anti-interleukin-2 receptor monoclonal antibodies in solid organ transplantation. As a post-doctoral scientist, he worked in the Transplantation Immunology Laboratory of Dr. Randall E. Morris at Stanford University (1998 – 2000).

3. Research Area

In December 2019, Teun van Gelder accepted a new position in Leiden University Medical Center (LUMC). He was appointed Professor in Drug Discovery & Development. LUMC, Leiden Institute of Chemistry, Leiden Academic Centre for Drug Research (LACDR), Centre for Human Drug Research (CHDR) and Leiden Bio Science Park (LBSP) together have the expertise and facilities for the design, development and testing of new innovative drugs. This environment is unique in the Netherlands, and provides an excellent basis for drug discovery and drug development

4. Conflict of interest

Speaker Buro for Astellas; Steering committee phase 3 trial for CSL Behring; Consultancy for Aurinia Pharma; Consultancy for Thermo Fisher Scientific